Ka. Morton et al., ENRICHMENT FOR METALLOTHIONEIN DOES NOT CONFER RESISTANCE TO CISPLATIN IN TRANSFECTED NIH 3T3 CELLS/, The Journal of pharmacology and experimental therapeutics, 267(2), 1993, pp. 697-702
Evidence has been presented both that metallothionein does and does no
t produce resistance to cisplatin. The metallothionein-enriched cells
described in most previous studies have been selected for resistance t
o heavy metals, such as cadmium, or have been maintained in a medium e
nriched for the metals. Exposure to toxic metals could alter the cells
in many ways. This report addresses the effect of metallothionein con
tent alone, independent of exposure to metals, on cellular resistance
to cisplatin. The toxicity of cisplatin was compared in NIH/3T3 cells
that vary in their content of metallothionein as a consequence of tran
sfection with a plasmid that results in the constitutive expression of
metallothionein. The plasmid contains the bovine papillomavirus genom
e and the mouse metallothionein-I gene; it is driven by a glucose-regu
lated protein of 78 kD. Control cells were transfected with a similar
plasmid in which the coding sequences for metallothionein were inverte
d and separated from the promoter, thereby abolishing expression. Expr
ession of metallothionein required neither selection nor maintenance o
f cells in the presence of heavy metals. Despite large differences bet
ween the two types of cells in their cellular content of metallothione
in and in their resistance to the toxicity of cadmium, no differences
in resistance to cisplatin were observed.